AVTXVSMRNA• 6 Months (Normalized)
AVTX vs MRNA (Avalo Therapeutics Inc. vs Moderna Inc.)
Showing Closing Date Range from Mar, 18 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVTX Performance $16.18
+10.22%
Avalo Therapeutics Inc.
Normalized Baseline0.00%
MRNA Performance $146.69
+179.94%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-169.72%
MRNA outperforming by 169.72%
AVTXMRNA
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVTX MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | AVTX Price | AVTX Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $16.18 | +10.22% | $146.69 | +179.94% | -169.72% |
| Sep 11, 2026 | $16.12 | +9.81% | $143.97 | +174.75% | -164.94% |
| Sep 10, 2026 | $17.18 | +17.03% | $136.62 | +160.73% | -143.70% |
| Sep 09, 2026 | $18.21 | +24.05% | $135.61 | +158.80% | -134.75% |
| Sep 08, 2026 | $19.71 | +34.26% | $140.33 | +167.81% | -133.55% |
| Sep 04, 2026 | $19.23 | +30.99% | $145.55 | +177.77% | -146.78% |
| Sep 03, 2026 | $19.00 | +29.43% | $148.87 | +184.10% | -154.67% |
| Sep 02, 2026 | $19.34 | +31.74% | $150.81 | +187.81% | -156.07% |
| Sep 01, 2026 | $18.95 | +29.09% | $154.27 | +194.41% | -165.32% |
| Aug 31, 2026 | $19.34 | +31.74% | $140.34 | +167.82% | -136.08% |
| Aug 28, 2026 | $19.59 | +33.45% | $137.99 | +163.34% | -129.89% |
| Aug 27, 2026 | $20.05 | +36.58% | $142.77 | +172.46% | -135.88% |
| Aug 26, 2026 | $20.55 | +39.99% | $149.66 | +185.61% | -145.62% |
| Aug 25, 2026 | $19.74 | +34.47% | $158.83 | +203.11% | -168.64% |
| Aug 24, 2026 | $19.27 | +31.27% | $138.89 | +165.06% | -133.79% |
Page 1 of 9